PharmaKing

Industry · 12 registered clinical trials.

Status	Trial	Phase	Started
Completed	Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis Non-Alcoholic Fatty Liver Disease	Phase 3	2019-11-15
Completed	Evaluate the Efficacy and Safety of N02RS1 in Patient With Acute Bronchitis Acute Bronchitis	Phase 2	2015-12-01
Completed	Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users Peptic Ulcer	Phase 2	2014-11-24
Completed	Efficacy and Safety of Oltipraz for Liver Fat Reduction in Patients With Non-Alcoholic Fatty Liver Disease Exc Non-alcholic Fatty Liver Disease	Phase 3	2014-02-01
Completed	Comparative Evaluate the Efficacy to Acute and Chronic Bronchitis Acute Exacerbation of Chronic Bronchitis	Phase 2	2013-11-01
Completed	Safety and the Pharmacokinetic Study of Characteristics of MKT-N2 (Montelukast) and Singulair® (Montelukast So Asthma and Allergic Rhinitis	Phase 1	2013-11-01
Completed	A Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of PMK-S005 After Gastritis, Gastric Ulcer	Phase 1	2012-12-01
Completed	To Evaluate the Efficacy of DDB/Garlic Oil in Patients With Elevated Transaminase Chronic Liver Disease Chronic Liver Disease	Phase 4	2012-04-01
Completed	Efficacy and Safety of Oltipraz in the Patients With Non-alcoholic Fatty Liver Disease Non-alcoholic Fatty Liver Disease	Phase 2	2011-05-01
Completed	Efficacy and Safety of MG in the Patients With Alcoholic Fatty Liver Disease and Alcoholic Hepatitis Alcoholic Fatty Liver Disease, Alcoholic Hepatitis	Phase 2	2010-11-01
Completed	Study to Evaluate Efficacy and Safety of PENNEL Capsule in the Patients With Chronic Liver Disease Chronic Liver Disease	Phase 3	1997-11-01
Completed	Study to Evaluate Efficacy, Safety and Tolerability of PENNEL Capsule in the Patients With Chronic Liver Disea Chronic Liver Disease	Phase 2	1996-12-01